Healthcare
Live Price
Offline$98.03
+0.14% today
1Y Change
-18.76%
Window
Jun 25, 2025 โ Jun 18, 2026
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Encompass Health Corporation (EHC) is a Healthcare stock with a market cap of $10.45B and listed on NYSE. The stock last traded around $98.03 and down 18.8% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +10.5%, EPS growth of +24.1%, a dividend yield of 0.7%. What stands out right now is revenue +10.5%, EPS +24.1%, free cash flow +21.9% with operating margin 17.9% and ROIC 13.3%. The dividend is present but secondary, with a yield around 0.7%. Valuation is more restrained than many high-expectation growth names at P/E 17.1 and price/sales 1.7. Stock Foundry combines EHC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+10.5% vs +7.6% peer median
Operating Margin
Near sector median
+17.9% vs +19.4% peer median
P/E
Below sector median
17.1 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 23, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +10.5% and EPS at +24.1%, with operating margin around 17.9%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.7%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.8% over the next 5 trading days and finished higher after 1 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 23, 2026 | โ | +0.1% | -1.8% | +2.5% |
2026 Feb 5, 2026 | +13.2% | +5.9% | +12.6% | +7.4% |
2025 Oct 29, 2025 | +3.4% | -7.0% | -8.2% | -7.5% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
EHC
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
EHC Max Drawdown
-26.22%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for EHC and SPY.

Company Overview
Encompass Health Corporation
New York Stock Exchange
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.